ArticleJournal of minimally invasive surgery2025
Laparoscopic right hepatectomy for hepatocellular carcinoma after sequential yttrium-90 liver radioembolization and liver venous deprivation (with video).
Article in Journal of minimally invasive surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Laparoscopic right hepatectomy has gained acceptance for major oncologic hepatectomies. Preoperative sequential strategies for induced tumor downsizing and contralateral liver hypertrophy ensure the safety of these major hepatectomies, especially in cases of underlying liver disease. In this video, we present a sequential minimally invasive approach used to treat a large hepatocellular carcinoma (HCC) developed in steatotic liver using sequentially yttrium-90 liver radioembolization (transarterial radioembolization), liver venous deprivation (LVD), and minimally invasive surgery. A computed tomography scan 30 days after the LVD procedure showed a future liver remnant hypertrophy rate of 89.8% and a kinetic growth rate of 5.4 mL/day. A laparoscopic right hepatectomy was then performed. Postoperative course was uneventful with bilirubin normalization at postoperative day 2. Patient was discharged on postoperative day 8. In case of voluminous HCC on steatosis liver, we provide an innovative combination of preoperative liver radioembolization and LVD to generate maximal liver hypertrophy and to allow a safe laparoscopic right hepatectomy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.